Relivion Product’s End User License AgreementUser License Agreement • August 31st, 2021
Contract Type FiledAugust 31st, 2021This End User License Agreement (“Agreement”) governs your engagement with Neurolief Ltd. (“Neurolief”, “Company” “we,” “us” “our”), with respect to your use of our (i) mobile application("App") as part of using the Neurolief’s Relivion®, an electronic device to treat migraine, that is developed and owned by Neurolief ("Relivion Product") (ii) The cloud-based platform (including its web interface) ("Platform") associated with the Relivion Product, which allows the upload and centralized management of the Relivion Product users’ data (collectively, the “Services”).